SPY328.95+2.43 0.74%
DIA266.52+2.17 0.82%
IXIC10,875.88+130.61 1.22%

H.C. Wainwright Reiterates Buy on Principia Biopharma, Raises Price Target to $63

H.C. Wainwright analyst Joseph Pantginis reiterates Principia Biopharma (NASDAQ:PRNB) with a Buy and raises the price target from $57 to $63.

Benzinga · -

H.C. Wainwright analyst Joseph Pantginis reiterates Principia Biopharma (NASDAQ:PRNB) with a Buy and raises the price target from $57 to $63.